SAA2 and coronary artery disorder: The expression of SAA in the HDL fraction was significantly higher in CHD patients than in controls (154.9±303.6 μg/mg of HDL vs. 48.6±154.5 μg/mg of HDL, P = 0.001) (Figure 3C), and the HDL-associated apoC-I was confirmed to be significantly decreased in CHD patients compared with controls (65.8±18.8 μg/mg of HDL vs. 71.7±23.0 μg/mg of HDL, P = 0.033) (Figure 3D).